PHG

Read Our Investor Brief on Koninklijke Philips

Shares of Health Care sector company Koninklijke Philips moved 2.3% today, and are now trading at a price of $21.54. The large-cap stock's daily volume was 528,720 compared to its average volume of 1,074,721. The S&P 500 index returned a 0.0% performance.

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company is based in Amsterdam and has 73,712 full time employees. Its market capitalization is $20,247,126,016.

3 analysts are following Koninklijke Philips and have set target prices ranging from $12.0 to $22.0 per share. On average, they have given the company a rating of underperform. At today's prices, PHG is trading 24.29% away from its average analyst target price of $17.33 per share.

The stock's 52 week high is $22.34 per share and its 52 week low is $11.75. Although Koninklijke Philips's average free cash flow over the last 4 years has been $685.0 Million, they have been decreasing at an average rate of -24.3%. For this reason, investors may continue to shun the stock.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cashflow ($ k) YoY Growth (%)
2022-12-31 -173,000 -806,000 -979,000 -213.05
2021-12-31 1,629,000 -763,000 866,000 -52.81
2020-12-31 2,777,000 -942,000 1,835,000 80.26
2019-12-31 2,031,000 -1,013,000 1,018,000 n/a
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS